Literature DB >> 24192989

Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation.

C Forni1, N Dusticier, A Nieoullon.   

Abstract

In vivo voltammetry was used in freely moving rats to study the processes whereby striatal dopamine (DA) release is regulated by corticostriatal glutamatergic neurons. Electrical stimulation of the cerebral cortex was found to markedly increase the striatal DA-related voltammetric signal amplitude. Similar enhancements have been observed after intracerebroventricular administration of 10nmoles glutamate, quisqualate and AMPA, whereas NMDA was found to decrease the amplitude of the striatal signals. The NMDA receptor antagonist APV did not significantly affect the voltammetric signal but prevented the NMDA-induced depression of the DA-related signals. These data are in agreement with those obtained in numerous previous studies suggesting that the glutamatergic corticostriatal neurons exert activatory effects on the striatal DA release via non-NMDA receptors. The mechanism involved might be of a presynaptic nature. The role of the NMDA receptors may however consist of modulating the dopaminergic transmission phasically and in a depressive way, which would be consistent with behavioural data suggesting the existence of a functional antagonism between the activity of the corticostriatal glutamatergic and nigrostriatal dopaminergic systems.

Entities:  

Year:  1992        PMID: 24192989     DOI: 10.1007/BF00806008

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  41 in total

1.  Comparative analysis of the effects of in vivo electrical stimulation of the frontal cortex and gamma-butyrolactone administration on dopamine and dihydroxyphenyl acetic acid (DOPAC) striatal contents in the rat.

Authors:  N Dusticier; A Nieoullon
Journal:  Neurochem Int       Date:  1987       Impact factor: 3.921

2.  Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.

Authors:  S P Butcher; J Liptrot; G W Aburthnott
Journal:  Neurosci Lett       Date:  1991-01-28       Impact factor: 3.046

3.  Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry.

Authors:  C Forni; P Brundin; R E Strecker; S el Ganouni; A Björklund; A Nieoullon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Effects of an N-methyl-D-aspartate receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique.

Authors:  H Kabuto; I Yokoi; K Mizukawa; A Mori
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

5.  Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter.

Authors:  R Hassler; P Haug; C Nitsch; J S Kim; K Paik
Journal:  J Neurochem       Date:  1982-04       Impact factor: 5.372

6.  Electrochemical detection of dopamine release in the striatum of freely moving hamsters.

Authors:  C Forni; A Nieoullon
Journal:  Brain Res       Date:  1984-04-09       Impact factor: 3.252

7.  Striatal glutamatergic function: modifications following specific lesions.

Authors:  P J Roberts; G J McBean; N A Sharif; E M Thomas
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

8.  Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes.

Authors:  J K Wang
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

9.  Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum.

Authors:  M O Krebs; F Trovero; M Desban; C Gauchy; J Glowinski; M L Kemel
Journal:  J Neurosci       Date:  1991-05       Impact factor: 6.167

10.  Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.

Authors:  P J Elliott; S P Close; D M Walsh; A G Hayes; A S Marriott
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1990
View more
  1 in total

1.  Regulation of dopamine levels in intrastriatal grafts of fetal mesencephalic cell suspension: an in vivo voltammetric approach.

Authors:  H Moukhles; C Forni; A Nieoullon; A Daszuta
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.